➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Baxter
Johnson and Johnson
Merck
Colorcon

Last Updated: October 24, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LURASIDONE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Lurasidone Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00044005 Safety and Tolerability Study of Drug to Treat Schizophrenia Completed Sunovion Phase 2 2002-09-01 The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia.
NCT00088621 A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia Completed Sunovion Phase 2 2004-07-01 A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia
NCT00088634 A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia Completed Sunovion Phase 2 2004-05-01 A 6-week in-patient and out-patient study to test the effectiveness and safety of a new medication in the treatment of schizophrenia
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lurasidone Hydrochloride

Condition Name

Condition Name for Lurasidone Hydrochloride
Intervention Trials
Schizophrenia 35
Bipolar Depression 13
Bipolar Disorder 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lurasidone Hydrochloride
Intervention Trials
Schizophrenia 38
Bipolar Disorder 20
Depression 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lurasidone Hydrochloride

Trials by Country

Trials by Country for Lurasidone Hydrochloride
Location Trials
United States 437
India 61
Japan 22
Ukraine 18
Russian Federation 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lurasidone Hydrochloride
Location Trials
California 37
New York 31
Texas 29
Florida 26
Pennsylvania 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lurasidone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Lurasidone Hydrochloride
Clinical Trial Phase Trials
Phase 4 9
Phase 3 36
Phase 2/Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lurasidone Hydrochloride
Clinical Trial Phase Trials
Completed 44
Recruiting 12
Not yet recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lurasidone Hydrochloride

Sponsor Name

Sponsor Name for Lurasidone Hydrochloride
Sponsor Trials
Sunovion 41
Sumitomo Dainippon Pharma Co., Ltd. 5
Target Health Inc. 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lurasidone Hydrochloride
Sponsor Trials
Industry 64
Other 28
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Express Scripts
Colorcon
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.